Ventura, CA, United States of America

Cynthia Hartley

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cynthia Hartley. Retrieved from https://idiyas.com/inventor/cynthia-hartley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cynthia Hartley: Innovator in Thrombopoietic Peptides

Introduction

Cynthia Hartley is a notable inventor based in Ventura, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of peptides with thrombopoietic activity. Her work has the potential to impact medical treatments related to platelet production.

Latest Patents

Cynthia holds 1 patent for her invention titled "Peptides and related compounds having thrombopoietic activity." This invention relates to novel peptides and compounds that can increase the production of platelets or platelet precursors, such as megakaryocytes, in mammals. This advancement could lead to new therapeutic options for patients with platelet deficiencies.

Career Highlights

Cynthia is currently employed at Amgen Inc., a leading biotechnology company known for its innovative approaches to medicine. Her role at Amgen allows her to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Cynthia has worked alongside talented colleagues, including Hosung Min and Karen C Sitney. These collaborations have fostered an environment of innovation and have been instrumental in advancing their shared research goals.

Conclusion

Cynthia Hartley's work in developing thrombopoietic peptides exemplifies the impact of innovation in biotechnology. Her contributions are paving the way for new treatments that could benefit many patients in need.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…